Request Sample Inquiry
Prenatal Genetic Testing Market

Prenatal Genetic Testing Market

Prenatal Genetic Testing Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

150

Base Year:

2022

Date

May - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2144

Segments Covered
  • By Technology By Technology Diagnostics Methods, Polymerase Chain Reaction, Array Comparative Genomic Hybridization (Acgh), Fluorescence In Situ Hybridization (FISH), Screening Methods, Non-Invasive Prenatal Tests, Maternal Serum Screening
  • By Screening Techniques By Screening Techniques Carrier Screening, Sequential Screening, Maternal Serum Quad Screening
  • By Diseases By Diseases Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Rare Diseases, Other Diseases
  • By End User By End User Hospitals, Clinics, Diagnostic Centers
  • By Product By Product Consumables, Assay Kits & Reagents, Disposables Instruments, Next Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Ultrasound Devices, Other Instruments
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 9.5 Billion
Revenue 2030Revenue 2030: USD 24.9 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 14.8%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Prenatal Genetic Testing Market - Segment Analysis
    1. Overview
    2. Global Prenatal Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Global Prenatal Genetic Testing Market - by Technology
      1. By Diagnostics Methods
      2. By Polymerase Chain Reaction
      3. By Array Comparative Genomic Hybridization (Acgh)
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Screening Methods
      6. By Non-Invasive Prenatal Tests
      7. By Maternal Serum Screening
    4. Global Prenatal Genetic Testing Market - by Screening Techniques
      1. By Carrier Screening
      2. By Sequential Screening
      3. By Maternal Serum Quad Screening
    5. Global Prenatal Genetic Testing Market - by Diseases
      1. By Alzheimer's Disease
      2. By Cancer
      3. By Cystic Fibrosis
      4. By Sickle Cell Anemia
      5. By Duchenne Muscular Dystrophy
      6. By Thalassemia
      7. By Huntington's Disease
      8. By Rare Diseases
      9. By Other Diseases
    6. Global Prenatal Genetic Testing Market - by End User
      1. By Hospitals
      2. By Clinics
      3. By Diagnostic Centers
    7. Global Prenatal Genetic Testing Market - by Product
      1. By Consumables
      2. By Assay Kits & Reagents
      3. By Disposables Instruments
      4. By Next Generation Sequencing Systems
      5. By Polymerase Chain Reaction Instruments
      6. By Microarrays
      7. By Ultrasound Devices
      8. By Other Instruments
    8. Global Prenatal Genetic Testing Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    9. Market comparative analysis
  4. North America Prenatal Genetic Testing Market - Segment Analysis
    1. Overview
    2. North America Prenatal Genetic Testing Market, 2016 - 2028 (USD Million)
    3. North America Prenatal Genetic Testing Market, by Technology
      1. By Diagnostics Methods
      2. By Polymerase Chain Reaction
      3. By Array Comparative Genomic Hybridization (Acgh)
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Screening Methods
      6. By Non-Invasive Prenatal Tests
      7. By Maternal Serum Screening
    4. North America Prenatal Genetic Testing Market, by Screening Techniques
      1. By Carrier Screening
      2. By Sequential Screening
      3. By Maternal Serum Quad Screening
    5. North America Prenatal Genetic Testing Market, by Diseases
      1. By Alzheimer's Disease
      2. By Cancer
      3. By Cystic Fibrosis
      4. By Sickle Cell Anemia
      5. By Duchenne Muscular Dystrophy
      6. By Thalassemia
      7. By Huntington's Disease
      8. By Rare Diseases
      9. By Other Diseases
    6. North America Prenatal Genetic Testing Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Diagnostic Centers
    7. North America Prenatal Genetic Testing Market, by Product
      1. By Consumables
      2. By Assay Kits & Reagents
      3. By Disposables Instruments
      4. By Next Generation Sequencing Systems
      5. By Polymerase Chain Reaction Instruments
      6. By Microarrays
      7. By Ultrasound Devices
      8. By Other Instruments
    8. North America Prenatal Genetic Testing Market, by Country
      1. U.S.
        1. U.S. Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. U.S. Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. U.S. Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. U.S. Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. U.S. Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      2. Canada
        1. Canada Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Canada Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Canada Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Canada Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Canada Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      3. Mexico
        1. Mexico Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Mexico Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Mexico Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Mexico Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Mexico Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
  5. Europe Prenatal Genetic Testing Market - Segment Analysis
    1. Overview
    2. Europe Prenatal Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Europe Prenatal Genetic Testing Market, by Technology
      1. By Diagnostics Methods
      2. By Polymerase Chain Reaction
      3. By Array Comparative Genomic Hybridization (Acgh)
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Screening Methods
      6. By Non-Invasive Prenatal Tests
      7. By Maternal Serum Screening
    4. Europe Prenatal Genetic Testing Market, by Screening Techniques
      1. By Carrier Screening
      2. By Sequential Screening
      3. By Maternal Serum Quad Screening
    5. Europe Prenatal Genetic Testing Market, by Diseases
      1. By Alzheimer's Disease
      2. By Cancer
      3. By Cystic Fibrosis
      4. By Sickle Cell Anemia
      5. By Duchenne Muscular Dystrophy
      6. By Thalassemia
      7. By Huntington's Disease
      8. By Rare Diseases
      9. By Other Diseases
    6. Europe Prenatal Genetic Testing Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Diagnostic Centers
    7. Europe Prenatal Genetic Testing Market, by Product
      1. By Consumables
      2. By Assay Kits & Reagents
      3. By Disposables Instruments
      4. By Next Generation Sequencing Systems
      5. By Polymerase Chain Reaction Instruments
      6. By Microarrays
      7. By Ultrasound Devices
      8. By Other Instruments
    8. Europe Prenatal Genetic Testing Market, by Country
      1. Germany
        1. Germany Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Germany Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Germany Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Germany Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Germany Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      2. UK
        1. UK Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. UK Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. UK Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. UK Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. UK Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      3. France
        1. France Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. France Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. France Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. France Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. France Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      4. Spain
        1. Spain Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Spain Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Spain Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Spain Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Spain Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      5. Italy
        1. Italy Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Italy Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Italy Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Italy Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Italy Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      6. BENELUX
        1. BENELUX Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. BENELUX Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. BENELUX Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. BENELUX Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. BENELUX Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      7. Rest of Europe
        1. Rest Of Europe Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Rest Of Europe Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Rest Of Europe Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Rest Of Europe Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Rest Of Europe Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
  6. Asia Pacific Prenatal Genetic Testing Market - Segment Analysis
    1. Overview
    2. Asia Pacific Prenatal Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Prenatal Genetic Testing Market, by Technology
      1. By Diagnostics Methods
      2. By Polymerase Chain Reaction
      3. By Array Comparative Genomic Hybridization (Acgh)
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Screening Methods
      6. By Non-Invasive Prenatal Tests
      7. By Maternal Serum Screening
    4. Asia Pacific Prenatal Genetic Testing Market, by Screening Techniques
      1. By Carrier Screening
      2. By Sequential Screening
      3. By Maternal Serum Quad Screening
    5. Asia Pacific Prenatal Genetic Testing Market, by Diseases
      1. By Alzheimer's Disease
      2. By Cancer
      3. By Cystic Fibrosis
      4. By Sickle Cell Anemia
      5. By Duchenne Muscular Dystrophy
      6. By Thalassemia
      7. By Huntington's Disease
      8. By Rare Diseases
      9. By Other Diseases
    6. Asia Pacific Prenatal Genetic Testing Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Diagnostic Centers
    7. Asia Pacific Prenatal Genetic Testing Market, by Product
      1. By Consumables
      2. By Assay Kits & Reagents
      3. By Disposables Instruments
      4. By Next Generation Sequencing Systems
      5. By Polymerase Chain Reaction Instruments
      6. By Microarrays
      7. By Ultrasound Devices
      8. By Other Instruments
    8. Asia Pacific Prenatal Genetic Testing Market, by Country
      1. China
        1. China Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. China Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. China Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. China Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. China Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      2. Japan
        1. Japan Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Japan Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Japan Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Japan Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Japan Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      3. India
        1. India Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. India Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. India Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. India Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. India Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      4. South Korea
        1. South Korea Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. South Korea Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. South Korea Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. South Korea Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. South Korea Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      5. South East Asia
        1. South East Asia Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. South East Asia Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. South East Asia Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. South East Asia Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. South East Asia Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Rest of Asia Pacific Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Rest of Asia Pacific Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Rest of Asia Pacific Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Rest of Asia Pacific Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
  7. Latin America Prenatal Genetic Testing Market - Segment Analysis
    1. Overview
    2. Latin America Prenatal Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Latin America Prenatal Genetic Testing Market, by Technology
      1. By Diagnostics Methods
      2. By Polymerase Chain Reaction
      3. By Array Comparative Genomic Hybridization (Acgh)
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Screening Methods
      6. By Non-Invasive Prenatal Tests
      7. By Maternal Serum Screening
    4. Latin America Prenatal Genetic Testing Market, by Screening Techniques
      1. By Carrier Screening
      2. By Sequential Screening
      3. By Maternal Serum Quad Screening
    5. Latin America Prenatal Genetic Testing Market, by Diseases
      1. By Alzheimer's Disease
      2. By Cancer
      3. By Cystic Fibrosis
      4. By Sickle Cell Anemia
      5. By Duchenne Muscular Dystrophy
      6. By Thalassemia
      7. By Huntington's Disease
      8. By Rare Diseases
      9. By Other Diseases
    6. Latin America Prenatal Genetic Testing Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Diagnostic Centers
    7. Latin America Prenatal Genetic Testing Market, by Product
      1. By Consumables
      2. By Assay Kits & Reagents
      3. By Disposables Instruments
      4. By Next Generation Sequencing Systems
      5. By Polymerase Chain Reaction Instruments
      6. By Microarrays
      7. By Ultrasound Devices
      8. By Other Instruments
    8. Latin America Prenatal Genetic Testing Market, by Country
      1. Brazil
        1. Brazil Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Brazil Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Brazil Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Brazil Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Brazil Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      2. Argentina
        1. Argentina Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Argentina Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Argentina Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Argentina Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Argentina Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      3. Rest of Latin America
        1. Rest of Latin America Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Rest of Latin America Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Rest of Latin America Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Rest of Latin America Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Rest of Latin America Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
  8. Middle East & Africa Prenatal Genetic Testing Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Prenatal Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Prenatal Genetic Testing Market, by Technology
      1. By Diagnostics Methods
      2. By Polymerase Chain Reaction
      3. By Array Comparative Genomic Hybridization (Acgh)
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Screening Methods
      6. By Non-Invasive Prenatal Tests
      7. By Maternal Serum Screening
    4. Middle East & Africa Prenatal Genetic Testing Market, by Screening Techniques
      1. By Carrier Screening
      2. By Sequential Screening
      3. By Maternal Serum Quad Screening
    5. Middle East & Africa Prenatal Genetic Testing Market, by Diseases
      1. By Alzheimer's Disease
      2. By Cancer
      3. By Cystic Fibrosis
      4. By Sickle Cell Anemia
      5. By Duchenne Muscular Dystrophy
      6. By Thalassemia
      7. By Huntington's Disease
      8. By Rare Diseases
      9. By Other Diseases
    6. Middle East & Africa Prenatal Genetic Testing Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Diagnostic Centers
    7. Middle East & Africa Prenatal Genetic Testing Market, by Product
      1. By Consumables
      2. By Assay Kits & Reagents
      3. By Disposables Instruments
      4. By Next Generation Sequencing Systems
      5. By Polymerase Chain Reaction Instruments
      6. By Microarrays
      7. By Ultrasound Devices
      8. By Other Instruments
    8. Middle East & Africa Prenatal Genetic Testing Market, by Country
      1. GCC Countries
        1. GCC Countries Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. GCC Countries Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. GCC Countries Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. GCC Countries Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. GCC Countries Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      2. South Africa
        1. South Africa Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. South Africa Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. South Africa Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. South Africa Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. South Africa Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Prenatal Genetic Testing Market, By Technology
          1. By Diagnostics Methods
          2. By Polymerase Chain Reaction
          3. By Array Comparative Genomic Hybridization (Acgh)
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Screening Methods
          6. By Non-Invasive Prenatal Tests
          7. By Maternal Serum Screening
        2. Rest of Middle East & Africa Prenatal Genetic Testing Market, By Screening Techniques
          1. By Carrier Screening
          2. By Sequential Screening
          3. By Maternal Serum Quad Screening
        3. Rest of Middle East & Africa Prenatal Genetic Testing Market, By Diseases
          1. By Alzheimer's Disease
          2. By Cancer
          3. By Cystic Fibrosis
          4. By Sickle Cell Anemia
          5. By Duchenne Muscular Dystrophy
          6. By Thalassemia
          7. By Huntington's Disease
          8. By Rare Diseases
          9. By Other Diseases
        4. Rest of Middle East & Africa Prenatal Genetic Testing Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Diagnostic Centers
        5. Rest of Middle East & Africa Prenatal Genetic Testing Market, By Product
          1. By Consumables
          2. By Assay Kits & Reagents
          3. By Disposables Instruments
          4. By Next Generation Sequencing Systems
          5. By Polymerase Chain Reaction Instruments
          6. By Microarrays
          7. By Ultrasound Devices
          8. By Other Instruments
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott (U.S.)
    2. Siemens Healthineers AG (Germany)
    3. Quidel Corporation (U.S.)
    4. F. Hoffman-La Roche Ltd. (Switzerland)
    5. Danaher. (U.S.)
    6. B.D. (U.S.)
    7. Chembio Diagnostics (U.S.)
    8. Trinity Biotech plc (Ireland)
    9. Instrumentation Laboratory (U.S.)
    10. Nova Biomedical (U.S.)
    11. PTS Diagnostics (U.S.)
    12. Sekisui Diagnostics (U.S.)
    13. Thermo Fisher Scientific (U.S.)
    14. DiaSorin S.p.A (Italy)
    15. AccuBioTech Co. Ltd. (China)
    16. Meridian Bioscience (U.S.)
    17. GeneSTAT Molecular Diagnostics
    18. LLC (U.S.)
    19. Terumo Corporation (Japan)
    20. Grifols
    21. S.A (Spain)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 25-May-2023
Global Prenatal Genetic Testing Market to Reach a Valuation of USD 24.9 Billion by 2030 – Rising Demand for Early Disease Detection and Non-Invasive Procedures to Drive Market Growth
FAQ
Frequently Asked Question

  • The global Prenatal Genetic Testing valued at USD 9.5 Billion in 2022 and is expected to reach USD 24.9 Billion in 2030 growing at a CAGR of 14.8%.

  • The prominent players in the market are Abbott (U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher. (U.S.), B.D. (U.S.), Chembio Diagnostics (U.S.), Trinity Biotech plc (Ireland), Instrumentation Laboratory (U.S.), Nova Biomedical (U.S.), PTS Diagnostics (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), DiaSorin S.p.A (Italy), AccuBioTech Co., Ltd. (China), Meridian Bioscience (U.S.), GeneSTAT Molecular Diagnostics, LLC (U.S.), Terumo Corporation (Japan), Grifols, S.A (Spain) .

  • The market is project to grow at a CAGR of 14.8% between 2023 and 2030.

  • The driving factors of the Prenatal Genetic Testing include

    • Increasing Rate of Genetic Disorders

  • North America was the leading regional segment of the Prenatal Genetic Testing in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy